Table of Contents
ISRN Cardiology
Volume 2012, Article ID 650915, 4 pages
http://dx.doi.org/10.5402/2012/650915
Research Article

Persistent Atrial Fibrillation Is Associated with Worse Prognosis Than Paroxysmal Atrial Fibrillation in Acute Cerebral Infarction

Department of Neurology, Haukeland University Hospital, 5021 Bergen, Norway

Received 22 May 2012; Accepted 29 August 2012

Academic Editors: W. S. Aronow, H. Nathoe, and B. Strasberg

Copyright © 2012 Halvor Naess et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Manegold et al., “Incidence of stroke in paroxysmal versus persistent/permanent atrial fibrillation and effects of oral anticoagulation or combined antiplatelet therapy: an ACTIVE W substudy,” European Heart Journal, vol. 27, Abstract 2711, 2006. View at Google Scholar
  2. L. Friberg, N. Hammar, and M. Rosenqvist, “Stroke in paroxysmal atrial fibrillation: report from the stockholm cohort of atrial fibrillation,” European Heart Journal, vol. 31, no. 8, pp. 967–975, 2010. View at Google Scholar · View at Scopus
  3. S. H. Hohnloser, D. Pajitnev, J. Pogue et al., “Incidence of stroke in paroxysmal versus sustained atrial fibrillation in patients taking oral anticoagulation or combined antiplatelet therapy. An ACTIVE W Substudy,” Journal of the American College of Cardiology, vol. 50, no. 22, pp. 2156–2161, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. R. Saxena and P. J. Koudstaal, “Anticoagulants for preventing stroke in patients with nonrheumatic atrial fibrillation and a history of stroke or transient ischaemic attack,” Cochrane Database of Systematic Reviews, no. 2, article CD000185, 2004. View at Google Scholar · View at Scopus
  5. H. Naess, J. Brogger, U. Waje-Andreassen, T. T. Idicula, and L. Thomassen, “Preadmission use of warfarin improves short-term outcome in patients with acute cerebral infarction,” Cerebrovascular Diseases, vol. 28, no. 1, pp. 8–12, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. N. M. Al-Saady, O. A. Obel, and A. J. Camm, “Left atrial appendage: structure, function, and role in thromboembolism,” Heart, vol. 82, no. 5, pp. 547–554, 1999. View at Google Scholar · View at Scopus
  7. A. L. Klein, R. A. Grimm, R. D. Murray et al., “Use of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation,” The New England Journal of Medicine, vol. 344, no. 19, pp. 1411–1420, 2001. View at Publisher · View at Google Scholar · View at Scopus
  8. V. Fuster, L. E. Rydén, D. S. Cannom et al., “ACC/AHA/ESC 2006 of the guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association task force on practice guidelines and the European Society of Cardiology Committee for practice guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society,” Circulation, vol. 114, no. 7, pp. 257–354, 2006. View at Google Scholar
  9. T. Watson, E. Shantsila, and G. Y. Lip, “Mechanisms of thrombogenesis in atrial fibrillation: virchow's triad revisited,” The Lancet, vol. 373, no. 9658, pp. 155–166, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. C. J. Johnson, S. J. Kittner, R. J. McCarter et al., “Interrater reliability of an etiologic classification of ischemic stroke,” Stroke, vol. 26, no. 1, pp. 46–51, 1995. View at Google Scholar · View at Scopus
  11. H. P. Adams Jr., B. H. Bendixen, L. J. Kappelle et al., “Classification of subtype of acute ischemic stroke: definitions for use in a multicenter clinical trial,” Stroke, vol. 24, no. 1, pp. 35–41, 1993. View at Google Scholar · View at Scopus
  12. J. Bamford, P. Sandercock, M. Dennis, J. Burn, and C. Warlow, “Classification and natural history of clinical identifiable subtypes of cerebral infarction,” The Lancet, vol. 337, no. 8756, pp. 1521–1526, 1991. View at Publisher · View at Google Scholar · View at Scopus
  13. T. Wessels et al., “Contribution of diffusion-weighted imaging in determination of stroke etiology,” American Journal of Neuroradiology, vol. 27, no. 1, pp. 35–39, 2006. View at Google Scholar
  14. R. G. Hart, L. A. Pearce, R. M. Rothbart, J. H. McAnulty, R. W. Asinger, and J. L. Halperin, “Stroke with intermittent atrial fibrillation: incidence and predictors during aspirin therapy,” Journal of the American College of Cardiology, vol. 35, no. 1, pp. 183–187, 2000. View at Publisher · View at Google Scholar · View at Scopus
  15. C. Marini, F. De Santis, S. Sacco et al., “Contribution of atrial fibrillation to incidence and outcome of ischemic stroke: results from a population-based study,” Stroke, vol. 36, no. 6, pp. 1115–1119, 2005. View at Publisher · View at Google Scholar · View at Scopus